ArticleAnnals of surgical oncology2020

CA19-9 Change During Neoadjuvant Therapy May Guide the Need for Additional Adjuvant Therapy Following Resected Pancreatic Cancer.

Hao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.